Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives

Microbiology

Volumn 156, Issue 11, 2010, Pages 3205-3215

  Salonen, Anne ^a   De Vos, Willem M ^a,b   Palva, Airi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL PAIN; BACTEROIDES; BIFIDOBACTERIACEAE; CLOSTRIDIUM; CONSTIPATION; DNA SEQUENCE; ECOSYSTEM; ERYSIPELOTHRIX; FIRMICUTES; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACHNOSPIRACEAE; NONHUMAN; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; REVIEW; RUMINOCOCCUS;

BACTERIA; BIOLOGICAL MARKERS; DNA, BACTERIAL; FECES; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; METAGENOME; PHYLOGENY;

EID: 78049496695     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.043257-0     Document Type: Review

References (58)

1. Aerssens, J., Camilleri, M., Talloen, W., Thielemans, L., Göhlmann, H. W., Van Den Wyngaert, I., Thielemans, T., De Hoogt, R., Andrews, C. N. & other authors (2008). Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 6, 194-205.
2. Bocci, V. (1992). The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect Biol Med 35, 251-260.
3. Bourdu, S., Dapoigny, M., Chapuy, E., Artigue, F., Vasson, M. P., Dechelotte, P., Bommelaer, G., Eschalier, A. & Ardid, D. (2005). Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 128, 1996-2008.
4. Carroll, I. M., Shen, X. J., Keku, T. O., Sartor, R. B. & Ringel, Y. (2008). Characterization of the fecal microbiota in patients with diarrhea predominant irritable bowel syndrome. Gastroenterology 134 (Suppl. 1), A681.
5. Carroll, I. M., Keku, T. O., Ringel-Kulka, T., Sartor, R. B. & Ringel, Y. (2010). Molecular characterization of the fecal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant IBS and healthy subjects. Gastroenterology 138 (Suppl. 1), S624.
6. Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A. & Wilson, I. (2002). Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122, 1778-1783.
7. Chassard, C., Dapoigny, M. C., Scott, K., Del'Homme, C., Dubray, C., Eschalier, A., Flint, H. J. & Bernalier-Donadille, A. (2009). The intestinal microbiota of irritable bowel syndrome patients is characterized by functional dysbiosis. Gastroenterology 136 (Suppl. 1), A214.
8. Codling, C., O'Mahony, L., Shanahan, F., Quigley, E. M. & Marchesi, J. R. (2010). A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 55, 392-397.
9. Drossman, D. A. (2000). The functional GI disorders and the Rome II process. In Rome II. The Functional Gastrointestinal Disorders, 2nd edn, pp. 1-30. Edited by D. A. Drossman, E. Corazziari, N. J. Talley, W. G. Thompson & W. E. Whitehead. McLean, VA: Degnon Associates.
10. Duck, L. W., Walter, M. R., Novak, J., Kelly, D., Tomasi, M., Cong, Y. & Elson, C. O. (2007). Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 13, 1191-1201.
11. Duncan, S. H., Louis, P., Thomson, J. M. & Flint, H. J. (2009). The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 11, 2112-2122.
12. Engelbrektson, A., Korzenik, J. R., Pittler, A., Sanders, M. E., Klaenhammer, T. R., Leyer, G. & Kitts, C. L. (2009). Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 58, 663-670.
13. Fleissner, C. K., Huebel, N., Abd El-Bary, M. M., Loh, G., Klaus, S. & Blaut, M. (2010). Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 5, 1-11.
14. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N. & Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104, 13780-13785.
15. Karantanos, T., Markoutsaki, T., Gazouli, M., Anagnou, N. P. & Karamanolis, D. G. (2010). Current insights in to the pathophysiology of irritable bowel syndrome. Gut Pathog 2, 3.
16. Kassinen, A., Krogius-Kurikka, L., Makivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J. & Palva, A. (2007). The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24-33.
17. Kerckhoffs, A. P., Samsom, M., van der Rest, M. E., de Vogel, J., Knol, J., Ben-Amor, K. & Akkermans, L. M. (2009). Lower bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 15, 2887-2892.
18. Khoruts, A., Dicksved, J., Jansson, J. K. & Sadowsky, M. J. (2010). Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44, 354-360.
19. King, T. S., Elia, M. & Hunter, J. O. (1998). Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352, 1187-1189.
20. Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L., Mäkivuokko, H., Kajander, K. & Palva, A. (2009). Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9, 95.
21. Lee, K. J. & Tack, J. (2010). Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil 22, 493-498.
22. Liu, C., Finegold, S. M., Song, Y. & Lawson, P. A. (2008). Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 58, 1896-1902.
23. Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F. & Spiller, R. C. (2006). Functional bowel disorders. Gastroenterology 130, 1480-1491.
24. Louis, P., Scott, K. P., Duncan, S. H. & Flint, H. J. (2007). Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 102, 1197-1208.
25. Louis, P., Young, P., Holtrop, G. & Flint, H. J. (2010). Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA : acetate CoA-transferase gene. Environ Microbiol 12, 304-314.
26. Lyra, A., Rinttilä, T., Nikkilä, J., Krogius-Kurikka, L., Kajander, K., Malinen, E., Mättö, J., Mäkelä, L. & Palva, A. (2009). Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 15, 5936-5945.
27. Macsharry, J, O'Mahony, L., Fanning, A., Bairead, E., Sherlock, G., Tiesman, J., Fulmer, A., Kiely, B., Dinan, T. G. & other authors (2008). Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Scand J Gastroenterol 43, 1467-1476.
28. Malinen, E., Rinttilä, T., Kajander, K., Mättö, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R. & Palva, A. (2005). Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373-382.
29. Malinen, E., Krogius-Kurikka, L., Lyra, A., Nikkilä, J., Jääskeläinen, A., Rinttilä, T., Vilpponen-Salmela, T., von Wright, A. & Palva, A. (2010). Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. WJG (in press).
30. Marsh, P. D. (2003). Are dental diseases examples of ecological catastrophes? Microbiology 149, 279-294.
31. Mättö, J., Maunuksela, L., Kajander, K., Palva, A., Korpela, R., Kassinen, A. & Saarela, M. (2005). Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43, 213-222.
32. Maukonen, J., Satokari, R., Mättö, J., Söderlund, H., Mattila-Sandholm, T. & Saarela, M. (2006). Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 55, 625-633.
33. Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J. & Quigley, E. M. M. (2010). The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59, 325-332.
34. Nakamura, N., Lin, H. C., McSweeney, C. S., Mackie, R. I. & Gaskins, H. R. (2010). Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease. Annu Rev Food Sci Technol 1, 363-395.
35. Parkes, G. C., Brostoff, J., Whelan, K. & Sanderson, J. D. (2008). Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol 103, 1557-1567.
36. Parkes, G. C., Sanderson, J. D. & Whelan, K. (2010). Treating irritable bowel syndrome with probiotics: the evidence. Proc Nutr Soc 69, 187-194.
37. Pimentel, M. & Lezcano, S. (2007). Irritable bowel syndrome: bacterial overgrowth - what's known and what to do. Curr Treat Options Gastroenterol 10, 328-337.
38. Pimentel, M., Lin, H. C., Enayati, P., van den Burg, B., Lee, H. R., Chen, J. H., Park, S., Kong, Y. & Conklin, J. (2006). Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 290, G1089-G1095.
39. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F. & other authors (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
40. Quigley, E. M. M. (2009). Review: do patients with functional gastrointestinal disorders have an altered gut flora? Therapeutic Advances in Gastroenterology 2 (Suppl. 4), s23-s30.
41. Rajilić-Stojanović, M. (2007). Diversity of the human gastrointestinal microbiota - novel perspectives from high throughput analyses. PhD thesis, University of Wageningen, The Netherlands.
42. Rana, S. V., Sharma, S., Sinha, S. K., Kaur, H., Sikander, A. & Singh, K. (2009). Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from north India. Dig Dis Sci 54, 132-135.
43. Ringel, Y. & Carroll, I. M. (2009). Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am 19, 141-150.
44. Scanlan, P. D., Shanahan, F. & Marchesi, J. R. (2008). Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol 8, 79.
45. Schoepfer, A. M., Schaffer, T., Seibold-Schmid, B., Muller, S. & Seibold, F. (2008). Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 20, 1110-1118.
46. Serra, J., Villoria, A., Azpiroz, F., Lobo, B., Santos, J., Accarino, A. & Malagelada, J. R. (2010). Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome. Neurogastroenterol Motil 22, 401-406.
47. Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P. & Doré, J. (2009). Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15, 1183-1189.
48. Spiller, R. & Garsed, K. (2009). Postinfectious irritable bowel syndrome. Gastroenterology 136, 1979-1988.
49. Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P. & Lochs, H. (2005). Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43, 3380-3389.
50. Tana, C., Umesaki, Y., Imaoka, A., Handa, T., Kanazawa, M. & Fukudo, S. (2010). Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 22, 512-519.
51. Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J. P., Ugarte, E., Munoz-Tamayo, R., Paslier, D. L. & other authors (2009). Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11, 2574-2584.
52. Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J. & Muller-Lissner, S. A. (1999). Functional bowel disorders and functional abdominal pain. Gut 45 (Suppl. 2), II43-II47.
53. Treem, W. R., Ahsan, N., Kastoff, G. & Hyams, J. S. (1996). Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 23, 280-286.
54. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A. & other authors (2009). A core gut microbiome in obese and lean twins. Nature 457, 480-484.
55. Vanhoutvin, S. A., Troost, F. J., Kilkens, T. O., Lindsey, P. J., Hamer, H. M., Jonkers, D. M., Venema, K. & Brummer, R. J. (2009). The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil 21, 952-e76.
56. Woese, C. R. (1987). Bacterial evolution. Microbiol Rev 51, 221-271.
57. Zhang, H., Dibaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R. & other authors (2009). Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106, 2365-2370.
58. Zoetendal, E. G., Rajilić-Stojanović, M. & de Vos, W. M. (2008). High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615.